CoChat

Pharmacotherapeutic targets in Alzheimer's disease

Open access
Biran, Yif'at, Masters, Colin L., Barnham, Kevin J., Bush, Ashley I., Adlard, Paul A. · 2009 · Journal of Cellular and Molecular Medicine
Cited by 57

The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.

Abstract

Current pharmacotherapies for the treatment of AD AD pharmacotherapies targeting τ AD pharmacotherapies targeting Aβ The metal hypothesis of AD AD pharmacotherapies targeting metal ions Alzheimer's disease (AD) is a progressive neurodegenerative disorder which is characterized by an increasing impairment in normal memory and cognitive processes that significantly diminishes a person's daily functioning. Despite decades of research and advances in our understanding of disease aetiology and pathogenesis, there are still no effective disease‐modifying drugs available for the treatment of AD. However, numerous compounds are currently undergoing pre‐clinical and clinical evaluations. These candidate pharma‐cotherapeutics are aimed at various aspects of the disease, such as the microtubule‐associated τ‐protein, the amyloid‐β (Aβ) peptide and metal ion dyshomeostasis – all of which are involved in the development and progression of AD. We will review the way these pharmacological strategies target the biochemical and clinical features of the disease and the investigational drugs for each category.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1582-4934.2008.00595.x

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 101 references

Cited by

See all 57

Metadata

Authors
Biran, Y., Masters, C. L., Barnham, K. J., Bush, A. I., & Adlard, P. A.
Venue
Journal of Cellular and Molecular Medicine
Publisher
Wiley
Published
2009-01
Volume
13
Issue
1
Pages
61-86
ISSN
  • 1582-1838 (ISSN-L)
  • 1582-4934
OpenAlex
W1985692753
Cited by
57
References
101
FWCI
3.42
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacotherapeutic targets in Alzheimer's disease. https://app.cochat.ai/papers/10.1111/j.1582-4934.2008.00595.x
The paper
Biran, Y., Masters, C. L., Barnham, K. J., Bush, A. I., & Adlard, P. A. (2009). Pharmacotherapeutic targets in Alzheimer's disease. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2008.00595.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.